Friday, March 31, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Boehringer Ingelheim
Steering Committee Chair
Professor
Pulmonary Department
Mainz University Hospital
Mainz, Germany
Family Physician and Clinical Lecturer
Department of Family and Community Medicine
University of Toronto
Toronto, Ontario, Canada
Honorary Professor of Primary Care
Observation Pragmatic Research Institute
Singapore, Singapore
Consultant and Senior Researcher
Coordinator of the Vall d'Hebron Center for Alpha-1 Antitrypsin Deficiency
Director of SEPAR COPD Research Network (PII)
Pneumology Department
Vall d'Hebron University Hospital and Research Institut (VHIR)
Barcelona, Spain
Director of Observational and Pragmatic Research Institute (OPRI)
Singapore, Singapore
Primary Care Respiratory Society
Professor of Primary Care Respiratory Medicine
University of Aberdeen
Aberdeen, Scotland, United Kingdom
Professor of Medicine
Head of Department
Department of Medicine
Pulmonary and Critical Care Medicine
University Medical Center Giessen and Marburg
Philipps-University Marburg
Marburg, Germany
Professor of Respiratory Medicine
Head Respiratory Division
National Heart and Lung Institute
Imperial College London
London, United Kingdom
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Berlin-Chemie; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Novartis; Sanofi
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Berlin-Chemie; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Novartis; Sanofi
Received grants for clinical research from: Boehringer Ingelheim; GlaxoSmithKline; Novartis; Roche
Disclosure: Alan Kaplan, MD, CCFP(EM), FCFP, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Behring; Boehringer Ingelheim; Covis; Novo Nordisk; Pfizer; Sanofi; Teva; Trudel; Valeo
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Bohringer Ingelheim; Covis; Cipla; GlaxoSmithKline; Merck; Pfizer; Teva; Sanofi; Spectrum; Trudel; Valeo
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Atriva Therapeutics; Bial; Boehringer Ingelheim; Chiesi; CSL Behring; GlaxoSmithKline; Gebro Pharma; Laboratorios Esteve; Ferrer; Mereo Biopharma; Novartis; ONO Pharma; Palobiofarma SL; pH Pharma; Sanofi; Spin Therapeutics; Takeda; Verona Pharma
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim; Chiesi; Cipla; CSL Behring; Grifols; Menarini; Novartis; Sandoz; Zambon
Received grants for clinical research from: Grifols
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amgen; AstraZeneca; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Mundipharma; Mylan; Novartis; Pfizer; Teva Pharmaceuticals; Theravance
Served as a speaker or a member of a speakers bureau for: Amgen; AstraZeneca; Boehringer Ingelheim; Chiesi; Cipla; Circassia; GlaxoSmithKline; Kyorin; Mundipharma; Mylan; Novartis; Regeneron Pharmaceuticals; Sanofi Genzyme; Teva Pharmaceuticals; Thermofisher
Received grants for clinical research from: AstraZeneca; Boehringer Ingelheim; Chiesi; Circassia; Mundipharma; Mylan; Novartis; Pfizer; Regeneron Pharmaceuticals; Sanofi Genzyme; Teva Pharmaceuticals; Theravance
Owns stock, stock options, or bonds from: AKL Research and Development Ltd;
Other: Educational Materials: Mundipharma; Novartis Travel Accommodations: AstraZeneca; Boehringer Ingelheim; Mundipharma; Mylan; Novartis; Thermofisher
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Aerogen; AstraZeneca; Boehringer Ingelheim; Chiesi; CSL Behring; GlaxoSmithKline; Grifols; Menarini; Novartis; Nuvaira
Served as a speaker or a member of a speakers bureau for: Aerogen; AstraZeneca; Boehringer Ingelheim; Chiesi; CSL Behring; GlaxoSmithKline; Grifols; Insmed; Menarini; Novartis
Received grants for clinical research from: AstraZeneca; Boehringer Ingelheim; Ciesi; CSL Behring; GlaxoSmithKline; Grifols; Novartis
Has disclosed the following relevant financial relationships:
Received grants for clinical research from: AstraZeneca; Boehringer Ingelheim; Chiesi; Genentech; GlaxoSmithKline; Novartis
